OrbiMed Advisors »

Pharvaris N V shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.7M 205k 27.75

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Sinovac Biotech SHS
Edwards Lifesciences (EW)
Upstream Bio (UPB)
Intuitive Surgical Com New (ISRG)
Sionna Therapeutics (SION)
Mbx Biosciences (MBX)
Argenx Se Sponsored Adr (ARGX)
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Terns Pharmaceuticals (TERN)

View all positions for OrbiMed Advisors

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Commodore Capital
Novo A/S
Wellington Management Company
Saturn V Capital Management
Cormorant Asset Management
5AM Venture Management
Sofinnova Ventures

View all funds holding Pharvaris N V